Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment

Life Sciences

Volumn 152, Issue , 2016, Pages 135-144

  Jordan, Brian C ^a   Mock, Charlotta D ^a   Thilagavathi, Ramasamy ^b   Selvam, Chelliah ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b KARPAGAM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; POLYPHENOL DERIVATIVE; ANTINEOPLASTIC AGENT;

ANTISEPSIS; CANCER MODEL; CURCUMA LONGA; DRUG EFFICACY; DRUG MECHANISM; FRUIT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; RED WINE; REVIEW; STRUCTURE ACTIVITY RELATION; VEGETABLE; WOUND HEALING; ANALOGS AND DERIVATIVES; ANIMAL; MALE; PROSTATIC NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CURCUMIN; HUMANS; MALE; PROSTATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84962850834     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.03.036     Document Type: Review

References (116)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal A cancer statistics, 2014 CA Cancer J. Clin. 64 2014 9 29
2. H. Akaza Asian trends in primary androgen depletion therapy on prostate cancer Cancer Biol. Med. 10 2013 187 191
3. P.D. Baade, D.R. Youlden, S.M. Cramb, J. Dunn, and R.A. Gardiner Epidemiology of prostate cancer in the Asia-Pacific region Prostate Int. 1 2013 47 58 http://www.cdc.gov/cancer/prostate/statistics/race.htm
4. M. Grossmann, A.S. Cheung, and J.D. Zajac Androgens and prostate cancer; pathogenesis and deprivation therapy Best Pract. Res. Clin. Endocrinol. Metab. 27 2013 603 616
5. X. Deng, G. He, J. Liu, F. Luo, X. Peng, S. Tang, Z. Gao, Q. Lin, J.M. Keller, and T. Yang Recent advances in bone-targeted therapies of metastatic prostate cancer Cancer Treat. Rev. 40 2014 730 738
6. H. Ting, G. Deep, C. Agarwal, and R. Agarwal The strategies to control prostate cancer by chemoprevention approaches Mutat. Res. 760 2014 1 15
7. E.D. Crawford, N.N. Stone, E.Y. Yu, P.J. Koo, S.J. Freedland, S.F. Slovin, L.G. Gomella, E.R. Berger, T.E. Keane, and P. Sieber Challenges and recommendations for early identification of metastatic disease in prostate cancer Urology 83 2014 664 669
8. D.M. Saman, A.M. Lemieux, M. Nawal Lutfiyya, and M.S. Lipsky A review of the current epidemiology and treatment options for prostate cancer Dis. Mon. 60 2014 150 154
9. C.A. Pettaway, L.E. Lamerato, M.T. Eaddy, J.K. Edwards, S.L. Hogue, and M.M. Crane Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence BJU Int. 108 2011 1302 1308
10. F. Rabbani, L.H. Yunis, K. Vora, J.A. Eastham, B. Guillonneau, P.T. Scardino, and K. Touijer Impact of ethnicity on surgical margins at radical prostatectomy BJU Int. 104 2009 904 908
11. K. Swords, E.M. Wallen, and R.S. Pruthi The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach Urol. Oncol. 28 2010 280 284
12. L.E. Pater, K.W. Hart, B.J. Blonigen, C.J. Lindsell, and W.L. Barrett Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population Am. J. Clin. Oncol. 35 2012 490 492
13. I.J. Powell, F.D. Vigneau, C.H. Bock, J. Ruterbusch, and L.K. Heilbrun Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men Cancer Epidemiol. Biomark. Prev. 23 2014 1505 1511
14. P. Tang, W. Du, K. Xie, J. Fu, H. Chen, W. Yang, and J.W. Moul Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: racial differences Prostate 72 2012 173 180
15. M. Fraser, A. Berlin, R.G. Bristow, and T. van der Kwast Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer Urol. Oncol. 33 2015 85 94
16. R. Espaldon, K.A. Kirby, K.Z. Fung, R.M. Hoffman, A.A. Powell, S.J. Freedland, and L.C. Walter Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold Urology 83 2014 599 605
17. F.H. Schroder Prostate cancer around the world. An overview Urol. Oncol. 28 2010 663 667
18. B.T. Helfand, and W.J. Catalona The epidemiology and clinical implications of genetic variation in prostate cancer Urol. Clin. North Am. 41 2014 277 297
19. R.L. Siegel, K.D. Miller, and A. Jermal Cancer statistics, 2015 CA Cancer J. Clin. 65 2015 5 29
20. T.J. Wallace, T. Torre, M. Grob, J. Yu, I. Avital, B. Brucher, A. Stojadinovic, and Y.G. Man Current approaches, challenges and future directions for monitoring treatment response in prostate cancer J. Cancer. 5 2014 3 24
21. A. Ahmed, S. Ali, and F.H. Sarkar Advances in androgen receptor targeted therapy for prostate cancer J. Cell. Physiol. 229 2014 271 276
22. J. Epstein, I.R. Sanderson, and T.T. MacDonald Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies Br. J. Nutr. 103 2010 1545 1557
23. N. Pescosolido, R. Giannotti, A.M. Plateroti, A. Pascarella, and M. Nebbioso Curcumin: therapeutical potential in ophthalmology Planta Med. 80 2014 249 254
24. R.C. Martin, H.S. Aiyer, D. Malik, and Y. Li Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects Food Chem. Toxicol. 50 2012 227 231
25. H. Zhou, C.S. Beevers, and S. Huang Targets of curcumin Curr. Drug Targets 12 2011 332 347
26. R. Furst, I. Zundorf, and et al. Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress Mediat. Inflamm. 146832 2014
27. A. Shehzad, J. Lee, and Y.S. Lee Curcumin in various cancers Biofactors 39 2013 56 68
28. A. Shehzad, Y.S. Lee, and et al. Molecular mechanisms of curcumin action: signal transduction Biofactors 39 2013 27 36
29. D.K. Walters, R. Muff, B. Langsam, W. Born, and B. Fuchs Cytotoxic effects of curcumin on osteosarcoma cell lines Investig. New Drugs 26 2008 289 297
30. T. Liu, C. Li, H. Sun, T. Luo, Y. Tan, D. Tian, and Z. Guo Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage Inflamm. Res. 63 2014 841 850
31. Y. Zhong, T. Liu, and Z. Guo Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-kappaB pathways in rat vascular smooth muscle cells Inflamm. Res. 61 2012 61 67
32. H. Zhou, C.S. Beevers, and S. Huang Targets of curcumin Curr. Drug Targets 12 2011 332 347
33. A. Shehzad, G. Rehman, and Y.S. Lee Curcumin in inflammatory diseases Biofactors 39 2013 69 77
34. A.K. Pereira, M.T. Garcia, W. Pinheiro, D. Ejzenberg, J.M. Soares, and E.C. Baracat Jr. What is the influence of cyclooxygenase-2 on postmenopausal endometrial polyps? Climacteric 18 2015 498 502
35. D. Akbik, M. Ghadiri, W. Chrzanowski, and R. Rohanizadeh Curcumin as a wound healing agent Life Sci. 116 2014 1 7
36. S.M. El-Bahr Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1 Phytother. Res. 29 2015 134 140
37. J. Trujillo, Y.I. Chirino, E. Molina-Jijon, A.C. Anderica-Romero, E. Tapia, and J. Pedraza- Chaverri Renoprotective effect of the antioxidant curcumin: recent findings Redox Biol. 1 2013 448 456
38. T. Sagiroglu, M. Kanter, M.A. Yagci, A. Sezer, and M. Erbogaet Protective effct of curcumin on cyclosporin A-induced endothelial dysfunction, antioxidant capacity, and oxidative damage Toxicol. Ind. Health 30 2014 316 327
39. M. Gazal, M.R. Valente, A. Acosta, F.N. Kaufmann, E. Braganhol, C.L. Lencina, F.M. Stefanello, G. Ghisleni, and M.P. Kaster Neuroprotective and antioxidant effects of curcumin in a ketamine-induce model of mania in rats Eur. J. Pharmacol. 724 2014 132 139
40. N. Eshghi, M. Asnaashari, H.H. Khodaparast, and F. Hosseini Evaluating the potential of natural curcumin for oxidative stability of soybean oil Nat. Prod. Res. 17 2014 1375 1378
41. S.P. Weisberg, R. Leibel, and D.V. Tortoriello Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity Endocrinology 149 2008 3549 3558
42. G. Naijil, T.R. Anju, S. Jayanarayanan, and C.S. Paulose Curcumin pretreatment mediates antidiabetogenesis via functional regulation of adrenergic receptor subtypes in the pancrease of multiple low-dose streptozotocin-induced diabetic rats Nutr. Res. 35 2015 823 833
43. D.C. Kim, S.K. Ku, and J.S. Bae Anticoagulant activities of curcumin and its derivative BMB Rep. 45 2012 221 226
44. P. Prakash, A. Misra, W.R. Surin, M. Jain, R.S. Bhatta, R. Pal, K. Raj, M.K. Barthwal, and M. Dikshit Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis Thromb. Res. 127 2011 111 118
45. S. Tajbakhsh, K. Mohammadi, I. Deilami, K. Zandi, M. Fouladvand, E. Ramedani, and G. Asayesh Antibacterial activity of indium curcumin and indium diacetylcurcumin Afr. J. Biotechnol. 7 2008 3832 3835
46. S.H. Mun, D.K. Joung, Y.S. Kim, O.K. Kang, S.B. Kim, Y.S. Seo, Y.C. Kim, D.S. Lee, D.W. Shin, K.T. Kweon, and D.Y. Kwon Synergestic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus Phytomedicine 20 2013 714 718
47. R. De, P. Kundu, S. Swarnakar, T. Ramamurthy, A. Chowdhury, G.B. Nair, and A.K. Mukhopadhyay Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice Antimicrob. Agents Chemother. 53 2009 1592 1597
48. R.S. Upendra, P. Khandelwal, and R.A.H. Manjunatha Turmeric powder (Curcuma longa Linn.) as an antifungal agents in plant tissue culture studies Int. J. Eng. Sci. 3 2011 1578 1581
49. H. Chowdhury, T. Banerje, and S. Walia In vitro screening of Curcuma longa L and its derivatives as antifungal agents against Helminthosporrum oryzae and Fusarium solani Pestic. Res. J. 20 2008 6 9
50. O.A.K. Khalilj, O.M.M. de Faria Oliveira, J.C.R. Vellosa, A. Urba de Quadros, L.M. Dalposso, T.K. Karam, M.R. Mainardes, and N.M. Khalil Curcumin antifungal and antioxidant activities are increased in the presence of ascorbic acid Food Chem. 133 2012 1001 1005
51. M. Sharma, R. Manoharlal, N. Puri, and R. Prasad Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans Biosci. Rep. 30 2010 391 404
52. S.H. Chung, S.H. Choi, J.A. Choi, R.S. Chuck, and C.K. Joo Curcumin suppresses ovalbumin-induced allergic conjunctivitis Mol. Vis. 18 2012 1966 1972
53. S.J.H. Lee, J.W. Kim, N.Y. Ko, S.S.H. Mun, E. Her, B.K. Kim, J.W. Han, H.Y. Lee, M.A. Beaven, Y.M. Kim, and W.S. Choi Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk J. Allergy Clin. Immunol. 12 2008 1225 1231
54. M. Suzuki, T. Nakamura, S. Iyoki, A. Fujiwara, Y. Watanabe, K. Mohri, K. Isobe, K. Ono, and S. Yano Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities Biol. Pharm. Bull. 28 2005 1438 1443
55. C.P.S. Subhashini, S. Kumari, D. Dash, and R. Sing Curcumin inhibits compound 48/80 induced systemic anaphylaxis AJLS 1 2013 165 170
56. S.R.M. Kinney, L. Carlson, J. Ser-Dolansky, C. Thompson, S. Shah, A. Gambrah, W. Xing, S.S. Schneider, and C.B. Mathias Curcumin ingestion inhibits mastocytosis and suppresses intestinal anaphylaxis in a murine model of food allergy PLoS ONE 10 2015 1 20
57. S. Takeda, H. Okazaki, E. Ikeda, S. Abe, Y. Yoshioka, K. Watanabe, and H. Aramaki Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells J. Toxicol. Sci. 39 2014 711 716
58. S. Biomente, A. Barbieri, G. Palma, D. Rea, A. Luciano, M. D'Aiuto, C. Arra, and F. Izzo Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer Biomed. Res. Int. 2015 878134
59. S. Hatamie, O. Akhavan, S.K. Sadrnezhaad, M.M. Ahadian, M.M. Shirolkar, and H.Q. Wang Curcumin-reduced grapheme oxide sheets and their effects on human breast cancer cells Mater. Sci. Eng. C 55 2015 482 489
60. D.T. Coleman, Y.H. Soung, Y.S. Surh, J.A. Cardelli, and J. Chung Curcumin prevents palmitoylation of integrin β4 in breast cancer cells PLoS ONE 10 2015 e0125399
61. K. Sun, X. Duan, H. Cai, X. Liu, Y. Yang, M. Li, X. Zhang, and J. Wang Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells Clin. Exp. Med. 1-11 2015
62. W.F. Hua, Y.S. Fu, Y.J. Liao, W.J. Xia, Y.C. Chen, Y.X. Zeng, H.F. Kung, and D. Xie Curcumin induces down-regulation of EZH2 expression through the MAPK pathwat in MDA-MB-435 human breast cancer cells Eur. J. Pharmacol. 637 2010 16 21
63. Q. Liu, T.Y.L. Wing, S.C.W. Sze, and Y.Tong Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation NF-κB, cyclinD and MMP-1 transcription Phytomedicine 16 2009 916 922
64. G. Chakraborty, S. Jain, S. Kale, R. Raja, S. Kumar, R. Mishra, and G.C. Kundu Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression Med.Mol. Rep. 1 2008 641 646
65. M.M. Yallapu, S. Khan, D.M. Maher, M.C. Ebeling, V. Sundram, N. Chauhan, A. Ganju, S. Balakrishna, B.K. Gupta, and N. Zafar Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer Biomaterials 35 2014 8635 8648
66. D. Mandair, R.E. Rossi, M. Pericleous, T. Whyand, and M.E. Caplin Prostate cancer and the influence of dietary factors and supplements: a systematic review Nutr. Metab. (Lond.) 11 2014 30
67. H.W. Chen, J.Y. Lee, J.Y. Huang, C.C. Wang, W.J. Chen, S.F. Su, C.W. Huang, C.C. Ho, J.J. Chen, M.F. Tsai, Y. Sl, and P.C. Yang Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1 Cancer Res. 68 2008 7428 7438
68. S.S. Lin, K.C. Lai, S.C. Hsu, J.S. Yang, C.L. Kuo, J.P. Lin, Y.S. Ma, C.C. Wu, and J.G. Chung Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF) Cancer Lett. 285 2009 127 133
69. J. Lee, Y.H. Im, H.H. Jung, J.H. Kim, J.O. Park, K. Kim, W.S. Kim, J.S. Ahn, C.W. Jung, Y.S. Park, W.K. Kang, and K. Park Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer Biochem. Biophys. Res. Commun. 334 2005 313 318
70. X. Xu, D. Chen, B. Ye, F. Zhong, and G. Chen Curcumin induces the apoptosis of non-small cell lung cancer cells through a calcium signaling pathway Int. J. Mol. Med. 35 2015 1610 1616
71. K. Zhang, X. Rui, and X. Yan Curcumin inhibits the proliferation and invasiveness of MHCC97-H cells via p38 signaling pathway Drug Dev. Res. 75 2014 463 468
72. K.S. Chun, Y.S. Keum, S.S. Han, Y.S. Song, S.H. Kim, and Y.J. Surh Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation Carcinogenesis 24 2003 1515 1524
73. J.M. Phillips, C. Clark, L. Herman-Ferdinandez, T. Moore-Medlin, X. Rong, G.J. Roberts, J.L. Clifford, F. Abreo, and C.A.O. Nathan Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo Otolaryngol. Head Neck Surg. 145 2011 58 63
74. J. Phillips, T. Moore-Medlin, K. Sonavane, O. Ekshyyan, J. McLarty, and C.A. Nathan Curcumin inhibits UV radiation-induced skin cancer in SKH-1 mice Otolaryngol. Head Neck Surg. 148 2013 797 803
75. C. Mohanty, and K.S. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 31 2010 6597 6611
76. J.S. Jurenka Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research Altern. Med. Rev. 14 2009 141 153
77. O.N. Gordon, P.B. Luis, H.O. Sintim, and C. Schneider Unraveling curcumin degradation: autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione J. Biol. Chem. 290 2015 4817 4828
78. A. Shehzad, F. Wahid, and Y.S. Lee Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials Arch. Pharm. 343 2010 489 499
79. H.Y. Choi, J.E. Lim, and J.H. Hong Curcumin interrupts the interaction between the androgen receptor and Wnt/beta-catenin signaling pathway in LNCaP prostate cancer cells Prostate Cancer Prostatic Dis. 13 2010 343 349
80. L.R. Chaudhary, and K.A. Hruska Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells J. Cell. Biochem. 89 2003 1 5
81. A. Mukhopadhyay, C. Bueso-Ramos, D. Chatterjee, P. Pantazis, and B.B. Aggarwal Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines Oncogene 20 2001 7597 7609
82. C.B. Piantino, F.A. Salvadori, P.P. Ayres, R.R. Kato, V. Srougi, K. Leite, and M. Srougi An evaluation of the anti-neouplastic activity of curcumin in prostate cancer cell lines Int. Braz. J. Urol. 35 2009 354 360
83. K.H. Tsui, T.H. Feng, C.M. Lin, P.L. Chang, and H.H. Juang Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells J. Androl. 29 2008 661 668
84. L. Yang, L. Chen, B. Meng, J. Suo, H. Wang, H. Xie, Q. Jin, L. Yao, R. Wang, and L. Zhang The effect of curcumin on proliferation and apoptosis in LNCaP prostate cancer cells CJCO 3 2006 55 60
85. L.C. Chung, K.H. Tsui, T.H. Feng, S.L. Lee, P.L. Chang, and H.H. Juang Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells Mol. Nutr. Food Res. 55 2011 1666 1676
86. Y. Du, Q. Long, L. Zhang, Y. Shi, X. Liu, X. Li, B. Guan, Y. Tian, X. Wang, and L. Li Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAO/mTOR/HIF-1α signaling Int. J. Oncol. 47 2015 2064 2072
87. X. Yu, T. Jing, H. Zhao, P. Li, W. Xu, and F. Shang Curcumin inhibits expression of inhibitor of DNA binding 1 in PC3 cell and xenografts Asian Pac. J. Cancer Prev. 15 2014 1465 1470
88. T. Dorai, J.P. Dutcher, D.W. Dempster, and P.H. Wiernik Therapeutic potential of curcumin in prostate cancer-IV: interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells Prostate 60 2004 1 17
89. H.N. Zhang, C.X. Yu, P.J. Zhang, W.W. Chen, A.L. Jiang, F. Kong, J.T. Deng, J.Y. Zhang, and C.Y. Young Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP Acta Pharmacol. Sin. 28 2007 423 430
90. L. Shu, T.O. Khor, J.H. Lee, S.S. Boyanapalli, Y. Huang, T.Y. Wu, C.L. Saw, K.L. Cheung, and A.N. Kong Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells AAPS J. 13 2011 606 614
91. J.H. Hong, K.S. Ahn, E. Bae, S.S. Jeon, and H.Y. Choi The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo Prostate Cancer Prostatic Dis. 9 2006 147 152
92. A.L. Hilchie, S.J. Furlong, K. Sutton, A. Richardson, M.R. Robichaud, C.A. Giacomantonio, N.D. Ridgway, and D.W. Hoskin Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria Nutr. Cancer 62 2010 379 389
93. D. Chendil, R.S. Ranga, D. Meigooni, S. Sathishkumar, and M.M. Ahmed Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 Oncogene 23 2004 1599 1607
94. J.H. Hong, G. Lee, and H.Y. Choi Effect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts Korean J. Urol. 56 2015 656 665
95. J. Yang, J. Ning, L. Peng, and D. He Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer Int. J. Clin. Exp. Pathol. 8 2015 9272 9278
96. T. Dorai, Y.C. Cao, D. Dorai, R. Buttyan, and A.E. Katz Therapuetic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo Prostate 47 2001 293 303
97. P.H. Killian, E. Kronski, K.M. Michalik, O. Barbieri, S. Astigiano, C.P. Sommerhoff, U. Pfeffer, A.G. Nerlich, and B.E. Bachmeier Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2 Carcinogenesis 33 2012 2507 2519
98. S. Thangavel, T. Yoshitomi, M.K. Sakharkar, and Y. Nagaski Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer J. Control. Release 209 2015 110 119
99. N.P. Aditya, M. Shim, I. Lee, Y.J. Lee, M.H. Im, and S. Ko Curcumin and Genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity J. Agric. Food Chem. 61 2013 1878 1883
100. P. Shukla, V. Mathur, A. Kumar, V. Khedgikar, V. Teja, D. Chaudhary, P. Kushwaha, H.K. Bora, R. Konwar, R. Trivedi, and P.R. Mishra Nanoemulsion based concomitant delivery of curcumin and etoposide: impact on cross talk between prostate cancer cells and osteoblast during metastasis J. Biomed. Nanotechnol. 10 2014 1 11
101. N.K. Narayanan, D. Nargi, C. Randolph, and B.A. Natayanan Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice Int. J. Cancer 125 2009 1 8
102. M.M. Yallapu, M. Jaggi, and S.C. Chauhan β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells Colloids Surf. B: Biointerfaces 79 2010 113 125
103. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells Macromol. Biosci. 10 2010 1141 1151
104. J.R. Fuchs, B. Pandit, D. Bhasin, J.P. Etter, N. Regan, D. Abdelhamid, C. Li, J. Lin, and P.K. Li Structure-activity relationship studies of curcumin analogues Bioorg. Med. Chem. Lett. 19 2009 2065 2069
105. L. Lin, Q. Shi, A.K. Nyarko, K.F. Bastow, C.C. Wu, C.Y. Su, C.C. Shih, and K.H. Lee Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents J. Med. Chem. 49 2006 3963 3972
106. A. Valentini, F. Conforti, A. Crispini, A. De Martino, R. Condello, C. Stellitano, G. Rostilio, M. Ghenini, G. Federici, S. Bernardini, and D. Pucci Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium (II) complex of curcumin on human prostate cancer cells J. Med. Chem. 52 2009 484 491
107. A. Mathur, Z.Y. Abd Elmageed, X. Liu, M. Kostochka, H. Zhang, A.B. Abdel-Mageed, and D. Mondal Subverting ER-stress toward apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells PLoS One 9 2014 e103109
108. J. Li, S.T. Xiang, Q.H. Zhang, J.J. Wu, Q. Tang, J.F. Zhou, L.J. Yang, Z.Q. Chen, and S.S. Hann Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERk 1/2-mediated targeting NF-κB/p65 and MUC1-C J. Exp. Clin. Cancer Res. 15 2015 46 57
109. D.W. Eom, J.H. Lee, Y.J. Kim, G.S. Hwang, S.N. Kim, J.H. Kwak, G.J. Cheon, K.H. Kim, H.J. Jang, J. Ham, K.S. Kang, and N. Yamabe Synergistic effect of curcumin on epigallocatechin gallate-induce anticancer action in PC3 prostate cancer cells BMB Rep. 48 2015 461 466
110. T.O. Khor, Y.S. Keum, and W. Lin Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice Cancer Res. 66 2006 613 621
111. H. Ide, S. Tokiwa, K. Sakamaki, K. Nishio, S. Isotani, S. Muto, T. Hama, H. Masuda, and S. Horie Combine inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen Prostate 70 2010 1127 1133
112. D. Deeb, H. Jiang, X. Gao, G. Divine, S.A. Dulchavshy, and S.C. Gautam Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis J. Exp. Ther. Oncol. 5 2005 81 91
113. D. Deeb, Y.X. Xu, and H. Jiang Curcumin(diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells Mol. Cancer Ther. 2 2003 95 103
114. https://clinicaltrials.gov/ct2/show/NCT0191890?term=curcumin+and+prostate&rank=1
115. https://clinicaltrials.gov/ct2/show/NCT02064673?term=curcumin+and+prostate&rank=2
116. https://clinicaltrials.gov/ct2/show/NCT02095717?tern=curcumin+and+prostate&rank=3